ResultsIQ › Latest results › J.G.Chemicals Limited
J.G.Chemicals Limited Q1 FY26 earnings call summary
NSE: JGCHEM · BSE: 544138
Earnings call of 12 Aug 2025, summarised by AI from the filing.
JG Chemicals Q1 FY26 revenue ₹221.4 cr, EBITDA ₹23.2 cr; board approves ₹100 cr Dahej capex for 40,000 MTPA Zinc chemicals facility.
Key takeaways
- Q1 FY26 results Consolidated revenue ₹221.4 cr, EBITDA ₹23.2 cr, PAT ₹16.35 cr.
- Dahej capex Board approved ₹100 cr greenfield capex for 40,000 MTPA Zinc chemicals facility at Dahej, funded through internal accruals, with potential to generate ₹900 cr revenue.
- Margin expansion EBITDA margin expected to increase by 200 to 300 basis points over the next few years.
- Zinc price risk Sharp movements in Zinc prices can impact inventory and quarterly EBITDA despite natural hedge.
J.G.Chemicals Limited Q1 FY27 results
As filed: Revenue ₹316 cr (+45% year on year), EBITDA ₹33.5 cr (+68% year on year), PAT ₹26.1 cr (+63% year on year), EBITDA margin 10.6% (+145 bps).
The Q1 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹286 cr (+28% year on year), EBITDA ₹21.5 cr (+13% year on year), PAT ₹18.9 cr (+18% year on year), EBITDA margin 7.5% (−98 bps). Score 77 of 100, Above trend. Revenue and profit growth were well above the company's own trend; EBITDA growth was above it. EBITDA margin fell 98 bps year on year. Share price after the results: +3.1% in 29 days (Nifty 500: −0.1%).
- Q3 FY26: Revenue ₹248 cr (+19% year on year), EBITDA ₹22.8 cr (+4% year on year), PAT ₹18.4 cr (+2% year on year), EBITDA margin 9.2% (−136 bps). Score 45 of 100, In line with trend. EBITDA margin fell 136 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −12.6% in 30 days (Nifty 500: −7.8%).
- Q2 FY26: Revenue ₹220 cr (+4% year on year), EBITDA ₹17.0 cr (−19% year on year), PAT ₹15.0 cr (−12% year on year), EBITDA margin 7.7% (−218 bps). Score 24 of 100, Below trend. EBITDA margin fell 218 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 6% from last quarter. Share price after the results: −11.1% in 28 days (Nifty 500: −0.5%).
- Q1 FY26: Revenue ₹218 cr (+7% year on year), EBITDA ₹20.0 cr (−9% year on year), PAT ₹16.0 cr (0% year on year), EBITDA margin 9.2% (−166 bps). Score 27 of 100, Below trend. EBITDA margin fell 166 bps year on year. Consolidated profit +0% but standalone +50%. Not enough history for a trend yet: scored on growth alone. Share price after the results: +0.9% in 30 days (Nifty 500: +1.9%).
- Q4 FY25: Revenue ₹224 cr (+24% year on year), EBITDA ₹19.0 cr (+12% year on year), PAT ₹16.0 cr (+14% year on year), EBITDA margin 8.5% (−91 bps). Score 57 of 100, In line with trend. EBITDA margin fell 91 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 11% from last quarter. Share price after the results: +11.5% in 30 days (Nifty 500: +1.0%).
- Q3 FY25: Revenue ₹209 cr, EBITDA ₹22.0 cr, PAT ₹18.0 cr, EBITDA margin 10.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹209 cr). Scored once a year-earlier consolidated quarter exists.
- Q2 FY25: Revenue ₹212 cr, EBITDA ₹21.0 cr, PAT ₹17.0 cr, EBITDA margin 9.9%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹212 cr). Scored once a year-earlier consolidated quarter exists.
Past price moves after results do not indicate future moves. Not a recommendation.
J.G.Chemicals Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (10 Aug 2026), Results deck (8 Aug 2026)
- Q4 FY26: Earnings call (15 May 2026), Results deck (14 May 2026)
- Q3 FY26: Earnings call (16 Feb 2026), Results deck (14 Feb 2026)
- Q2 FY26: Earnings call (17 Nov 2025), Results deck (14 Nov 2025)
- Q1 FY26: Earnings call (12 Aug 2025), Results deck (11 Aug 2025)
- Q4 FY25: Results deck (19 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.